Nicotinic acetylcholine receptor ligands

Details for Australian Patent Application No. 2005317280 (hide)

Owner AstraZeneca AB

Inventors Chang, Hui-Fang; Horchler, Carey; Chapdelaine, Marc; Herzog, Keith J.; Phillips, Eifion

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005317280

PCT Pub. Number WO2006/065209

Priority 60/636,362 15.12.04 US; 60/643,319 12.01.05 US

Filing date 13 December 2005

Wipo publication date 22 June 2006

International Classifications

C07D 498/20 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/065209 Priority application(s): WO2006/065209

9 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005317285-Tri (hydroxymethyl) methylamine salt or an ethanol amine salt of (2S) - 2-ethoxy-3- (4-{2- [hexyl (2phenylethyl) amino] - 2 -oxoethoxy} phenyl) propanoic acid

2005317279-Purification of immunoglobulins